Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
05/2005
05/12/2005US20050100969 Substrate for fabricating protein microarrays
05/12/2005US20050100963 KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
05/12/2005US20050100955 Immunoglobulin direceted towards colon specific gene (CSG) for use in classification, treatment and prevention of cell proliferative disorders; diagnostic imaging; gene expression inhibition; immunotherapy
05/12/2005US20050100953 Using presence of single nucleotide polymorphism in thrombospondin-2 gene as diagnostic/prognostic screening tool in detection of cardiovascular disorders
05/12/2005US20050100945 Fluorescent polysiloxanes
05/12/2005US20050100944 Correlating cellular morphology with presence of target nucleic acid sequence by staining and hybridizing with fluorescently labeled nucleic acid probe; use in prognostic, diagnostic, or research applications
05/12/2005US20050100943 Using solid suport comprising a plurality of immobilized probes for detecting peptides, proteins and preferential DNA; gene expression analysis; genomics; proteomics
05/12/2005US20050100942 Nucleotide sequences coding RNA for use in identifying modulators for prevention and treatment of cell proliferative disorders
05/12/2005US20050100939 System and methods for enhancing signal-to-noise ratios of microarray-based measurements
05/12/2005US20050100938 Microarray for detection of biopolymer; microelectrode array for electrochemical sensing
05/12/2005US20050100936 Methods and compositions related to prediction of drug response
05/12/2005US20050100934 Method for assaying protein-protein interaction
05/12/2005US20050100933 determine prognosis of a subject having breast cancer by use of gene expression profiles, or patterns; bioassay
05/12/2005US20050100932 Sequencing a polynucleotide; stopping an extension cycle in a sequence by synthesis reaction before the reaction has run to near or full completion
05/12/2005US20050100931 Using tumor antigen expression profiles before and after exposure to testosterone and/or bicalutamide as diagnostic tool in determining efficacy as antitumor agents
05/12/2005US20050100930 Magnetic nanoparticles, magnetic detector arrays, and methods for their use in detecting biological molecules
05/12/2005US20050100929 Advance signal processing; automatic detectors; efficient separation ; using computers
05/12/2005US20050100927 Using transgenic corynebacterium which over expresses dihydropicolinate synthase to ferment lysine for use in cosmetics, medicines and animal feeds
05/12/2005US20050100926 Risk assessment for adverse drug reactions
05/12/2005US20050100925 MUC17 encoding nucleic acid sequences, polypeptides, antibodies and methods of use thereof
05/12/2005US20050100922 Fluid analyzing apparatus
05/12/2005US20050100921 Genomics applications for modified OLIGO nucleotides
05/12/2005US20050100920 Nucleic acid encoding Bacillus stearothermophilus polc polymerase subunit
05/12/2005US20050100919 Apparatus comprising solid support for use in detection of non-nucleic acid target molecules; microarrays; high throughput assay
05/12/2005US20050100915 Nucleic acid amplification and detection of Mycobacterium species
05/12/2005US20050100914 Using methylation profile of testes-specific protease (TSP50) genes as disgnoatic tool in detection of breast cancer
05/12/2005US20050100911 Using microarray hybridization followed by dilution and amplification as tools in monitoring gene expression; genotyping; identifying restriction fragment length polymorphisms
05/12/2005US20050100910 Amplifying a nucleic acid; ligating different oligomers hybridizable to primers of the same melting temperature, simultaneous PCR of the groups of DNA fragments ligated with the oligomers, detecting PCR amplified DNA fragments
05/12/2005US20050100909 Microarray for detecting allelic variants which reduce efficacy of interferon therapies as a treatment of hepatitis c infection
05/12/2005US20050100906 especially that encodes an immunoglobulin constant region such as the Fc portion of human IgG1.
05/12/2005US20050100905 Immobilization; solid phase synthesis; quantitative/qualitative analysis; polymorphisms; drug screening; lyophilization; kits
05/12/2005US20050100904 Using surface plasmon resonance analyzer to monitor physiological response of immobilized cells to external stimuli; in vitro drug testing and screening
05/12/2005US20050100903 Screening method
05/12/2005US20050100900 Using solid support comprising immobilized primer and cyclic replication as tools in propagattion of preferential nucleotide sequences; gene expression analysis; identifying restriction fragment length polymorphisms
05/12/2005US20050100899 Analysing gene expression occurring in a microorganism before, during or after contact with or adhesion of the microorganism to an artificial lipid bilayer; micbiocides; antiinfective agents
05/12/2005US20050100898 Compositions and methods for genetic analysis of polycystic kidney disease
05/12/2005US20050100897 NFAT transcription factors in tumor progression
05/12/2005US20050100896 Amino acid sequences comprising dombrook antigens for use as diagnostic tool in transfusion medicine; blood typing
05/12/2005US20050100895 Using conditionally replication-competent adenoviruses transcription as diagnostic indicator of cell proliferative disorders of alimentary canal; tissue targeted therapy; drug delivery
05/12/2005US20050100894 Novel mitogen activated kinase
05/12/2005US20050100893 Detection of nucleic acid reactions on bead arrays
05/12/2005US20050100892 Expression vector comprising nucleotide sequences coding bacterial insecticidal protein for use in transformation and propagation of disease resistant crop plants; biological pest control
05/12/2005US20050100891 Identifying modulators which control endothelial cell and viral gene expression; diagnosis and treatment of cell proliferative disorders; viricides; anticancer agents
05/12/2005US20050100890 Viron for use as gene transfer construct; gene therapy and tissue targeted therapy; drug delivery
05/12/2005US20050100889 Oligonucleotides and methods for detecting hepatitis C viral nucleic acids
05/12/2005US20050100888 Using transcription factor profiles and vectors comprising reporter molecules under regulatory control of transcrption factor as tool in detection of cell proliferative disorders
05/12/2005US20050100887 Using kinase assay to identify modulators of viral infection; viricides; high throughput assay
05/12/2005US20050100885 Compositions and methods for the treatment of severe acute respiratory syndrome (SARS)
05/12/2005US20050100884 Using nematode model to identify modulator for prevention and treatment of vesicular stomatitis virus infection
05/12/2005US20050100883 Peptide-based diagnostic reagents for SARS
05/12/2005US20050100882 Viral polypeptide fusion comprising guanylyltransferase, methyltransferase and polymerase activities for use as tool in identifying modulator of viral propagation; viricides
05/12/2005US20050100880 Testing apparatus comprising several detachable test pieces with multi-layered electrodes for use in the simultaneous measurement of several biological functions
05/12/2005US20050100879 Methods for the identification of inhibitors of flavanone 3-hydroxylase expression or activity in plants
05/12/2005US20050100817 Compositions, systems, and methods for imaging
05/12/2005US20050100555 Synovial tissue binding peptide; amino acid sequence motifs; identify binding peptides by grafting tissue of first species into second having attenuated immunological response
05/12/2005US20050100552 Baculovirus vector, expressed in insect cells; induce apoptosis; introduced into tumor cell by viral vector, liposome, a conjugate, injection, electroporation, particle bombardment
05/12/2005US20050100547 Also a method for detecting an agent capable of binding TRAF2 binding site of sphingosine kinase by contacting cells with a putative agent and detecting an altered expression phenotype
05/12/2005US20050100540 Platelet-activating factor acetylhydrolase
05/12/2005US20050098841 Nanopore chip with n-type semiconductor
05/12/2005US20050098434 Separation channel having at least one in- and outlet opening at the beginning and at the end of the channel and one electrode in the region of the inlet opening and one electrode in the region of the outlet opening; separation channel is subdivided into at least two sections in series
05/12/2005US20050098433 Electrochemical sensor strip
05/12/2005US20050098432 Circuit for electrochemical sensor strip
05/12/2005US20050098431 Electrochemical cell
05/12/2005CA2557623A1 Detection of a microorganism by detecting modification of a peptide substrate and a biosensor for same
05/12/2005CA2557612A1 Methods, peptides and biosensors useful for detecting a broad spectrum of bacteria
05/12/2005CA2551074A1 Hcv ns3-ns4a protease resistance mutants
05/12/2005CA2549971A1 Methods of identifying individuals at risk of perioperative bleeding, renal dysfunction or stroke
05/12/2005CA2544708A1 Liver cancer biomarkers
05/12/2005CA2544481A1 Compositions and methods for detecting severe acute respiratory syndrome coronavirus
05/12/2005CA2544373A1 Blood test prototypes and methods for the detection of circulating tumor and endothelial cells
05/12/2005CA2544367A1 Compositions, methods and detection technologies for reiterative oligonucleotide synthesis
05/12/2005CA2544262A1 Gel-shell beads with adsorbed or bound biomolecules
05/12/2005CA2544041A1 Optimization of gene expression analysis using immobilized capture probes
05/12/2005CA2543999A1 Monkey npy y4 receptor and method of evaluating compound
05/12/2005CA2543966A1 Angiogensis models using nestin-expressing stem cells to image nascent blood vessels
05/12/2005CA2543954A1 Method of designing sirnas for gene silencing
05/12/2005CA2543763A1 Bacterial virulence factors and uses thereof
05/12/2005CA2543538A1 Hbv variants detection and application
05/12/2005CA2543528A1 Placental stem cells and uses thereof
05/12/2005CA2543451A1 High troughput functional assay for g-protein coupled receptors using a rap-ras chimeric protein
05/12/2005CA2543144A1 Methods and compositions for identifying therapeutic compounds
05/12/2005CA2543142A1 Methods and compositions for identifying therapeutic compounds
05/12/2005CA2543127A1 Primate prokineticin and prokineticin receptor polypeptides, related compositions and methods
05/12/2005CA2543091A1 Apparatus and method for dispensing fluid, semi-solid and solid samples
05/12/2005CA2542992A1 Method for identifying compounds that affect expression of tryptophan hydroxylase isoform 2
05/12/2005CA2542768A1 Fluorescent probes for dna detection by hybridization with improved sensitivity and low background
05/12/2005CA2542542A1 Method of detecting a quantity of methylation at a locus
05/12/2005CA2540167A1 Systems and methods for detecting biological features
05/12/2005CA2538695A1 Clq related protein
05/12/2005CA2536565A1 Expression profiling using microarrays
05/12/2005CA2534236A1 Lipoparticles comprising proteins, methods of making, and using the same
05/12/2005CA2505471A1 Fluorescence assay for mtp activity
05/11/2005EP1530046A1 Method for distinguishing AML subtypes with aberrant and prognostically intermediate karyotypes
05/11/2005EP1530043A1 Analytic chip for quantifying nucleic acid concentration, analytic device for quantifying nucleic acid concentration and analytic method for quantifying nucleic acid concentration
05/11/2005EP1529849A2 Reliable method for assessing and reporting the risks of disease, contamination and losses caused by one or more microorganisms in a matrix or environment
05/11/2005EP1529848A1 Substances, sequences and methods for identifying epidemic methicillin resistant Staphylococcus aureus strains
05/11/2005EP1529847A1 Method for detecting methicillin resistant Staphylococcus aureus (MRSA)
05/11/2005EP1529846A1 Means and methods for classifying cyanobacteria
05/11/2005EP1529841A1 RNA extraction method, RNA extraction reagent, and method for analyzing biological materials
05/11/2005EP1529216A1 Method for diagnosing multiple sclerosis